Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of 1.18 trillion as of April 29, 2026. Its market cap has decreased by -38.98% in one year.

Market Cap

1.18T

Enterprise Value

1.28T

Revenue

309.06B

Ranking

n/a

PE Ratio

11.51

Stock Price

262.80

Market Cap Chart

Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.18T, an increase of 2,455.81%. That is a compound annual growth rate of 11.74%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	1,175.73B	-18.65%
Dec 30, 2025	1,445.24B	-47.87%
Dec 30, 2024	2,772.28B	-10.93%
Dec 29, 2023	3,112.33B	46.89%
Dec 30, 2022	2,118.80B	26.50%
Dec 30, 2021	1,674.99B	69.77%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Genmab	105.04B
Coloplast	93.02B
ALK-Abelló	50.03B
Demant	43.28B
H. Lundbeck	42.17B
Zealand Pharma	21.44B
Ambu A/S	17.24B
Bavarian Nordic	14.31B

Market Cap Rankings